DexCom Inc. (DC4)
XETR
75.60
+0.60 (+0.80%)
Closed
Oct 7, 2026
Day's Range
73.6075.60
52 wk Range
47.0079.60
Financial Statements - DC4 - DexCom Inc.
Revenue
4.66B▲ 37.1%
Net Income
836.30M▲ 72.2%Net Margin 17.9%
EBITDA
1.35B▲ 70.4%
Free Cash Flow
1.07B▲ 102.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.66B | 3.39B | 3.45B | 2.77B | 2.33B | 1.83B |
| Cost of Goods | 1.86B | 1.34B | 1.27B | 979.45M | 732.65M | 616.84M |
| Gross Profit | 2.80B | 2.05B | 2.18B | 1.79B | 1.60B | 1.22B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 911.80M | 505.73M | 570.19M | 373.19M | 253.56M | 285.71M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 82.20M | -5.22M | -1.90M | -5.34M | 7.72M | -5.62M |
| Pre Tax Income | 1.08B | 597.60M | 677.70M | 372.81M | 244.98M | 214.64M |
| Income Tax | 252.10M | 111.93M | 161.12M | 47.31M | 38.06M | -256.23M |
| Net Income | 836.30M | 485.67M | 516.58M | 325.49M | 206.91M | 470.88M |
| EPS Basic | 2.14 | 1.46 | 1.4 | 0.88 | 0.4 | 1.3075 |
| EPS Diluted | 2.09 | 1.42 | 1.3 | 0.82 | 0.3875 | 1.265 |
| Basic Shares Outstanding | 390.20M | 331.76M | 386M | 389.40M | 386.80M | 377.60M |
| Diluted Shares Outstanding | 390.20M | 331.76M | 386M | 389.40M | 386.80M | 377.60M |
| Ebit | 1.10B | 613.62M | 697.07M | 390.55M | 262.91M | 295.44M |
| Ebitda | 1.35B | 797.12M | 874.51M | 539.28M | 360.31M | 365.08M |
| Net Income Continuous Operations | 836.30M | 485.67M | 516.58M | 325.49M | 206.91M | 470.88M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
